Abstract
Articular cartilage has limited intrinsic healing potential due to the fact that it is avascular and the presence of few specialized cells with a low mitotic activity. Trauma and/or chronic irritation may lead to progressive damage, joint degeneration, and early osteoarthritis (OA).
Cartilage lesions on the patellofemoral joint present a frequent source of pain and dysfunction especially in active patients. Various associated pathologies such as objective or potential patellar instability, muscular dysfunction, and biomechanical disorders of the foot, knee, and hip might act as a cause of patellofemoral pain syndrome, and they should be investigated and addressed when necessary.
Several conservative treatment options (such as oral and topical nonsteroidal anti-inflammatory drugs (NSAIDs), diacerein, and intra-articular corticosteroids and viscosupplementation) have been utilized and have yielded short-term efficacy and local or systemic side effects. Platelet-rich plasma (PRP) represents a therapeutic application with promising preliminary clinical results, in terms of reducing symptoms and knee inflammation in patients with symptomatic cartilage lesions or chondropathy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hunter W. Of the structure and disease of articulating cartilages. 1743. Clin Orthop Relat Res. 1995;317:3–6.
Mankin HJ. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am. 1982;64(3):460–6.
Bellamy N, Campbell J, Robinson V, Gee T, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2, CD005328.
Habib GS. Systemic effects of intra-articular corticosteroids. Clin Rheumatol. 2009;28(7):749–56.
Habib GS, Saliba W, Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol. 2010;29(4):347–56.
Zhang W, Nuki G, Moskowitz RW, Abramson S, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–99.
Kon E, Buda R, Filardo G, Di Martino A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):472–9.
Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil. 2010;89(12):961–9.
Filardo G, Kon E, Buda R, Timoncini A, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):528–35.
Wang-Saegusa A, Cugat R, Ares O, Seijas R, et al. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131(3):311–7.
Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012;4(2):162–72.
Mazzucco L, Balbo V, Cattana E, Guaschino R, et al. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: FibrinetR, RegenPRP-KitR, PlateltexR and one manual procedure. Vox Sang. 2009;97(2):110–8.
Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg. 1993;165(6):728–37.
Nakagawa K, Sasho T, Arai M, et al. Effects of autologous platelet-rich plasma on the metabolism of human articular chondrocytes. Osteoarthr Cartil. 2007;15(Suppl 2):B134
Anitua E, Sanchez M, Nurden AT, et al. New insights into and novel applications for platelet rich and fibrin therapies. Trends Biotechnol. 2006;24(5):227–34.
Anitua E, Sanchez M, Οrive G, Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007;28:4551–60.
Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002;84-A(6):1032–44. Review.
Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng. 2003;9 Suppl 1:S5–15. Review.
Akeda K, An HS, Okuma M. Platelet rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006;14(12):1272–80.
Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, et al. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy. 2010;26(2):269–78.
Sánchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39(5):345–54.
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.
Brittberg M, Aglietti P, Gambardella R, et al. International Cartilage Repair Society (ICRS) classification. The ICRS clinical cartilage injury evaluation system. Presented at the International Knee Society Meeting, Sweden; 2000.
Wu W, Chen F, Liu Y, Ma Q, et al. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg. 2007;65(10):1951–7.
Frisbie D, Kawcak C, Werpy N, et al. Clinical biochemical and histological effects of intraarticular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 2007;68(3):290–6.
Saito M, Takahashi KA, Arai Y, Inoue A, et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol. 2009;27(2):201–7.
Cugat R, Carrillo JM, Serra I, et al. Articular cartilage defects reconstruction by plasma rich growth factors. In Zanasi S et al. (eds.)., Basic science, clinical repair and reconstruction of articular cartilage defects: current status and prospects. Bologna, Italy. TIMEO. 2006:801–7.
Block JA, Shakoor N. Lower limb osteoarthritis: biomechanical alterations and implications for therapy. Curr Opin Rheumatol. 2010;22(5):544–50.
Gomoll A, Farr J. Future developments in cartilage repair. In: Cole B, Gomoll A, editors. Biologic joint reconstruction. Thorofare: SLACK Incorporated.
Harrison S, Vavken P, Kevy S, Jacobson M, et al. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med. 2011;39(4):729–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 ISAKOS
About this chapter
Cite this chapter
Karnatzikos, G., Chaurasia, S., Gobbi, A. (2014). Platelet-Rich Plasma for the Treatment of Symptomatic Patellofemoral Cartilage Lesions. In: Gobbi, A., Espregueira-Mendes, J., Nakamura, N. (eds) The Patellofemoral Joint. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54965-6_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-54965-6_33
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54964-9
Online ISBN: 978-3-642-54965-6
eBook Packages: MedicineMedicine (R0)